Pharma Marketing News Vol. 10, No. 12: 20 July 2011
Welcome to Volume 10, Issue #12 (20 JULY 2011) of Pharma Marketing News.
Is There an Upward Career Path for Pharma Social Media Pioneers?
Are we witnessing an exodus of social media
Digitally-Feeble Pharma
Is Your Brand a Digital Genius or a Feeble-Minded Idiot? When it comes to digital IQ, some brands are geniuses and some are feeble-minded idiots, according to the 'L2 Digital IQ Index' for pharmaceutical brands, a first-of-its kind measurement of the digital competence of 51 pharma brands across eight therapeutic categories.
Pharma Marketing News Vol. 10, No. 17: 10 November 2011
Welcome to Volume 10, Issue #17 (10 NOVEMBER 2011) of Pharma Marketing News.
Pharma Marketing News Vol. 10, No. 2: JANUARY 19, 2011
Welcome to Volume 10, Issue #2 (JANUARY 19, 2011) of Pharma Marketing News.
Events I Witnessed, News You Made, & People We Met
The year 2010 was all about me. By 'me' I mean Pharmaguy, which is the Twitter handle and Facebook name of John Mack, Editor and Publisher of Pharma Marketing News. It's all about YOU too! This is where you can 'sign' the 2010 Pharma Marketing Yearbook and and document that you were part of it all.
Pharma Marketing News Vol. 10, No. 19: 21 December 2011
Welcome to Volume 10, Issue #19 (21 DECEMBER 2011) of Pharma Marketing News.
The Big C in the Big Apple
HepC.tv is featuring the video 'Man-on-the-Street: New Yorkers' Reactions to the Big Yellow C.' Is it effective? How do we know?
Are Sales Reps as “Useful” as PhRMA Wants Us to Believe?
Let's Look at Some Data PhRMA Doesn't Mention. PhRMA pointed out that nearly 9 out of 10 physicians considered company-sponsored peer education programs to be 'up-to-date, useful and reliable.'
The British Pharmaceutical Industry Issues Social Media Guidance for Adverse Event Reporting
Once again the Brits have beaten the US in issuing useful guidelines for social media use by the pharmaceutical industry! As I reported back in April, 2011, the Prescription Medicines Code of Practice Authority (PMCPA), which oversees the self-regulatory code of the Association of the British Pharmaceutical Industry (ABPI), published
